JMAR to Showcase BioSentry at AWWA Conference; More Than 15,000 Water Executives to View Laser-Based Water Monitoring System at Annual Industry Event
The presentation, "Recent Results in Real-time, Continuous Detection of Pathogens in Water" will highlight the BioSentry(TM) and show how it can help industry professionals improve water quality monitoring operations and increase water distribution security by leveraging the system's real-time detection of microorganisms.
“The AWWA Annual Conference and Exposition offers the perfect opportunity to expose BioSentry(TM) to an important customer base”
"The AWWA Annual Conference and Exposition offers the perfect opportunity to expose BioSentry(TM) to an important customer base," said Ronald A. Walrod, CEO of JMAR. "Our system puts water quality information in the hands of decision makers in real time, allowing them to effectively monitor their operations. Furthermore, we can tailor the system to screen for the microorganisms most likely to appear in a specific water supply, making it a targeted and efficient tool."
For the past 123 years, the AWWA Annual Conference and Exposition has served as the definitive source of information for water professionals who work to improve the quality and supply of drinking water in North America and beyond. The exhibition includes more than 500 participating organizations.
Interested attendees may also learn more about the BioSentry(TM) system at JMAR's booth, # 2148.
The BioSentry(TM) is a laser-based early-warning system that will provide continuous, automated quality monitoring of drinking water. This unique system is designed to monitor, detect and classify waterborne microorganisms in real time, assuring water purity. BioSentry(TM) is useful for a number of water processes and applications such as potable water treatment and water distribution systems. It can also be used in homeland security, military, protection of government buildings, and a number of industrial applications.
Beta units of the system are currently undergoing field testing at several sites including a North San Diego County-based municipal water treatment plant, a major Mexican beverage manufacturer and a leading luxury cruise line provider. Production units are expected to be available in Q4 of 2005.
JMAR Technologies, Inc. is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging over a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries while continuing to carry out research and development for the U.S. Defense Advanced Research Projects Agency (DARPA) and support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotechnology, bioscience and semiconductor industries with its Britelight(TM) Laser; X-ray Light Source; Compact X-ray Microscope - for 3D visualization of single cells and polymers; and its X-ray Nano Probe - enabling interaction, analysis and materials modification at the nano-scale. JMAR also develops, manufactures and markets its BioSentry(TM) microorganism early warning system and maintains a strategic alliance for the production of the READ chemical sensor for homeland security, environmental and utility infrastructure industries.
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the risk that the performance validation tests of the BioSentry Beta units are not successfully completed due to unforeseen issues with the installation and operation of the units outside of the controlled environment of JMAR's facility, competition from alternative particle detection, filtering and other water decontamination technologies, uncertainties as to the size of the market, cost and margins for the BioSentry products, failure to obtain market acceptance, current or future government regulations affecting the use of BioSentry products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 8-K filed on March 30, 2005 with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.